Clinical Trials Logo

Clinical Trial Summary

This project will follow babies with ichthyosis over time in order to better understand the natural course of ichthyosis in infants and children and to examine how specific genetic mutations affect clinical characteristics.


Clinical Trial Description

The investigators hypothesize that early complications and comorbidities in infants with congenital ichthyosis are genotype-dependent, such that clinical standards of care can be tailored to the genetic diagnoses. Definition of clinical groups based upon phenotype may also provide useful predictors of outcome. Information gained from this study will provide the basis for the development of rational standards of care for the future management of children with congenital ichthyosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02655861
Study type Observational
Source Yale University
Contact
Status Terminated
Phase
Start date June 2015
Completion date June 5, 2019

See also
  Status Clinical Trial Phase
Completed NCT03051347 - Asthma and Atopic Dermatitis Validation of PROMIS Pediatric Instruments N/A
Completed NCT00004690 - Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis Phase 3
Completed NCT00074685 - National Registry for Ichthyosis and Related Disorders
Completed NCT03641261 - Therapeutic Education Using an Internet Application in Hereditary Ichthyosis N/A
Completed NCT03796052 - Study Determining Safety and Efficacy of Avena Sativa (Oat) Skincare Products for Treating Skin Dryness and Itching in Cancer Patients N/A
Recruiting NCT05954416 - FARD (RaDiCo Cohort) (RaDiCo-FARD)
Active, not recruiting NCT05295732 - The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis Phase 3
Recruiting NCT03464994 - Ophthalmological Abnormalities in Hereditary Ichthyosis (ICHTYO-KERATO) N/A
Recruiting NCT03417856 - Defining the Skin and Blood Biomarkers of Ichthyosis
Terminated NCT04697056 - A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis Phase 2
Recruiting NCT06330350 - Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Enrolling by invitation NCT06330324 - Reproductive Options in Inherited Skin Diseases
Completed NCT03041038 - The Efficacy and Safety of Secukinumab in Patients With Ichthyoses Phase 2
Not yet recruiting NCT06362447 - Efficacy of Injectable Gentamicin in Hereditary Ichthyosis Phase 2
Active, not recruiting NCT04549792 - An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With Ichthyoses Early Phase 1